Search Menu
Photonics Media Photonics Buyers' Guide Photonics Spectra BioPhotonics EuroPhotonics Vision Spectra Photonics Showcase Photonics ProdSpec Photonics Handbook
More News

Biolase Laser Receives FDA OK for First Nondental Surgery

Facebook Twitter LinkedIn Email Comments
IRVINE, Calif., May 9, 2013 — Dental laser maker Biolase Inc.'s WaterLase iPlus all-tissue laser has been cleared by the US Food and Drug Administration for soft-tissue use in orthopedic and podiatric surgery, the company announced Wednesday. It is the first nondental clearance for its flagship product.

Biolase Chairman and CEO Federico Pignatelli said the approval expands the product into two markets, each with tremendous potential. "Just the top ten orthopedic surgical soft-tissue procedures, for example, offer a $2.6 billion market opportunity for our WaterLase technology."

The iPlus was cleared for incision, excision, resection, ablation, vaporization, coagulation and hemostasis, with or without an arthroscope, in contact and noncontact with tissue, in orthopedic and podiatric surgery, including soft and cartilaginous tissue in small and large joints.

"During the past several years, the use of lasers in orthopedic surgery has become more accepted as a less-invasive alternative to conventional surgery, and it has become clear that modern lasers will play a significant role in the treatment of musculoskeletal injuries," said Dr. Amado Carino, the company's global clinical affairs manager.

For more information, visit:
May 2013
ablationAmado CarinoAmericasBiolaseBiophotonicsBusinessCaliforniacartilagedental laserFDAFederico Pignatellifood and drug administrationfoot surgeryiPlusjointsorthopedicpodiatrictissue laserWaterLaselasers

back to top
Facebook Twitter Instagram LinkedIn YouTube RSS
©2019 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA,

Photonics Media, Laurin Publishing
x We deliver – right to your inbox. Subscribe FREE to our newsletters.
We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.